A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis

NCT07237568 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: LNK01001
DRUG: Placebo

Sponsor

Lynk Pharmaceuticals Co., Ltd